Unknown

Dataset Information

0

Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic Conditioning.


ABSTRACT:

Background

Remote ischemic conditioning (RIC) has been beneficial in laboratory studies of anthracycline cardiotoxicity, but its effects in patients is not established.

Objectives

The authors studied the effect of RIC on cardiac biomarkers and function during and after anthracycline chemotherapy.

Methods

The ERIC-Onc study (Effect of Remote Ischaemic Conditioning in Oncology Patients; NCT02471885) was a randomized, single-blind, sham-controlled study of RIC at each chemotherapy cycle. The primary endpoint was troponin T (TnT) during chemotherapy and up to 1 year. Secondary outcomes included cardiac function, major adverse cardiovascular events (MACE), and MACE or cancer death. Cardiac myosin-binding-protein C (cMyC) was investigated in parallel with TnT.

Results

The study was prematurely halted after the evaluation of 55 patients (RIC n = 28, sham n = 27). Biomarkers increased from baseline to cycle 6 of chemotherapy for all patients (median TnT 6 [IQR: 4-9] ng/L to 33 [IQR: 16-36)] ng/L; P ≤ 0.001; cMyC 3 (IQR: 2-5) ng/L to 47 (IQR: 18-49) ng/L; P ≤ 0.001). Mixed-effects regression analysis for repeated measures showed no difference in TnT between the 2 groups (RIC vs sham, mean difference 3.15 ng/L; 95% CI: -0.04 to 6.33; P = 0.053), or cMyC (RIC vs sham, mean difference 4.17 ng/L; 95% CI: -0.12 to 8.45; P = 0.056). There were more MACE and cancer deaths in the RIC group (11 vs 3; HR: 0.25; 95% CI: 0.07-0.90; P = 0.034), with more cancer deaths (8 vs 1; HR: 0.21; 95% CI: 0.04-0.95; P = 0.043) at 1 year.

Conclusions

TnT and cMyC significantly increased during anthracycline chemotherapy with 81% having a TnT ≥14 ng/L at cycle 6. RIC did not affect the rise in biomarkers, but there was a small increase in early cancer deaths, possibly related to the greater proportion of patients with metastatic disease randomized to the RIC group (54%vs 37%). (Effect of Remote Ischaemic Conditioning in Oncology Patients [ERIC-ONC]; NCT02471885).

SUBMITTER: Mallouppas M 

PROVIDER: S-EPMC10308041 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic Conditioning.

Mallouppas Michael M   Chung Robin R   Ghosh Arjun K AK   Macklin Alison A   Yellon Derek M DM   Walker J Malcolm JM  

JACC. CardioOncology 20230502 3


<h4>Background</h4>Remote ischemic conditioning (RIC) has been beneficial in laboratory studies of anthracycline cardiotoxicity, but its effects in patients is not established.<h4>Objectives</h4>The authors studied the effect of RIC on cardiac biomarkers and function during and after anthracycline chemotherapy.<h4>Methods</h4>The ERIC-Onc study (Effect of Remote Ischaemic Conditioning in Oncology Patients; NCT02471885) was a randomized, single-blind, sham-controlled study of RIC at each chemothe  ...[more]

Similar Datasets

| S-EPMC4297315 | biostudies-other
| S-EPMC8576053 | biostudies-literature
| S-EPMC8902383 | biostudies-literature
| S-EPMC6191186 | biostudies-literature
| S-EPMC8207229 | biostudies-literature
| 2703482 | ecrin-mdr-crc
| S-EPMC8878575 | biostudies-literature
| S-EPMC6490705 | biostudies-literature
| S-EPMC7169943 | biostudies-literature
| S-EPMC8135236 | biostudies-literature